The corporate card provider was valued at $2.1bn in a round led by Tencent that increased its funding to $380m altogether.

Leaps by Bayer co-led an oversubscribed round for the oncology therapeutics developer, with the proceeds to go to clinical trials and supplementary licences.

Tencent co-led the cross-border human resources provider’s latest round, which included pre-series B funding raised in the second half of 2021.

SoftBank Vision Fund 2 led the e-commerce automation software developer’s latest round, helping it reach unicorn status and lift its total funding to almost $200m.

The consumer lending platform developer raked in nine figures through a round backed by strategic partner JP Morgan.

The on-demand grocery provider secured funding from Astra International and Syngenta as it looks to grow geographically.

Country Garden Venture Capital was among the investors in the Qualcomm-backed contract chip manufacturing service provider’s latest round, which took its total funding to $630m.

Deutsche Telekom-backed DTCP was among the investors that pushed the cybersecurity management platform developer’s valuation to $2.6bn.

Axa Venture Partners and MassMutual Ventures returned for the insurance comparison marketplace’s latest round, which included Brighthouse Financial, Global Atlantic Financial, IA Financial, Lincoln Financial and Pacific Life.

Triumvera, co-founded by McMaster's professor Jonathan Bramson, looks to progress its solid tumour therapeutic candidate.